Abstract
Genital infection by human papillomavirus (HPV) tends to occur more frequently in patients with conditions associated with immune suppression. Systemic lupus erythematosus (SLE) is an immunological disorder characterized by generalized inflammation and a number of clinical manifestations and circulating autoantibodies. The aim of the present study was to determine the prevalence of genital HPV infection among female SLE patients. Women diagnosed with SLE based on American College of Rheumatology classification criteria followed at rheumatology outpatient clinic of the Escola Bahiana de Medicina e Saude Publica, Salvador, Brazil, were included in the study. As a comparison group, clinically healthy women who were attending the gynecology outpatient clinic for routine examination at the same institution were recruited. Testing for cervical HPV infection was performed using the nested polymerase chain reaction technique. Eighty-eight female SLE patients (mean age, 41.4 ± 11.6 years) and seventy healthy female subjects (control group) were studied. The prevalence of HPV infection was 80.7 % (71/88) in the SLE group and 35.7 % (25/70) in the control group (p < 0.0001). After adjustment of the variables (early sexual activity, number of partners and obstetric history), the odds ratio (OR) for genital HPV infection in women with SLE was 7.2 (95 % CI, 2.9 to 17.8; p = 0.0001). The use of immunosuppressive drugs was not associated with a higher prevalence of HPV infection. This study demonstrated that SLE patients have a higher prevalence of genital HPV infection, even when exposed to less potential risk factors for the virus.
Similar content being viewed by others
References
Lizano M, Berumen J, Garcia-Carranca A (2009) HPV-related carcinogenesis: basic concepts, viral types and variants. Arch Med Res 40(6):428–434
Munoz N (2000) Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19(1–2):1–5
Veldhuijzen NJ, Snijders PJ, Reiss P, Meijer CJ, van de Wijgert JH (2010) Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis 10(12):862–874
Grinsztejn B, Veloso VG, Levi JE, Velasque L, Luz PM, Friedman RK et al (2009) Factors associated with increased prevalence of human papillomavirus infection in a cohort of HIV-infected Brazilian women. Int J Infect Dis 13(1):72–80
Santana IU, Gomes AD, Lyrio LD, Rios Grassi MF, Santiago MB (2011) Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review. Clin Rheumatol 30(5):665–672
Ognenovski VM, Marder W, Somers EC, Johnston CM, Farrehi JG, Selvaggi SM et al (2004) Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. J Rheumatol 31(9):1763–1767
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277
Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M et al (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287(16):2114–2119
Richart RM (1990) A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol 75(1):131–133
Demathe A, Bernabé DG, Garcia JF, Nunes CM, Miyahara GI (2010) Comparação entre dois métodos de detecção de DNA de papilomavírus humano em carcinoma epidermoide de lábio. J Bras Patol Med Lab 46:85–90
Tam LS, Chan AY, Chan PK, Chang AR, Li EK (2004) Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum 50(11):3619–3625
Barros BRC, Matschinske R, Silva MB, Skare TL (2007) Prevalence of abnormal pap smears in patients with systemic lupus erythematosus. Rev Bras Reumatol 47(5):325–329
Dhar JP, Kmak D, Bhan R, Pishorodi L, Ager J, Sokol RJ (2001) Abnormal cervicovaginal cytology in women with lupus: a retrospective cohort study. Gynecol Oncol 82(1):4–6
Nath R, Mant C, Luxton J, Hughes G, Raju KS, Shepherd P et al (2007) High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum 57(4):619–625
Freitas TP, Carmo BB, Paula FD, Rodrigues LF, Fernandes AP, Fernandes PA (2007) Molecular detection of HPV 16 and 18 in cervical samples of patients from Belo Horizonte, Minas Gerais, Brazil. Rev Inst Med Trop Sao Paulo 49(5):297–301
Barber C, Gold WL, Fortin PR (2011) Infections in the lupus patient: perspectives on prevention. Curr Opin Rheumatol 23(4):358–365
Cuchacovich R, Gedalia A (2009) Pathophysiology and clinical spectrum of infections in systemic lupus erythematosus. Rheum Dis Clin North Am 35(1):75–93
Ramos-Casals M, Cuadrado MJ, Alba P, Sanna G, Brito-Zeron P, Bertolaccini L et al (2008) Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature. Medicine (Baltimore) 87(6):311–318
Pugliese A, Beltramo T, Torre D, Roccatello D (2007) Parvovirus B19 and immune disorders. Cell Biochem Funct 25(6):639–641
Aslanidis S, Pyrpasopoulou A, Kontotasios K, Doumas S, Zamboulis C (2008) Parvovirus B19 infection and systemic lupus erythematosus: activation of an aberrant pathway? Eur J Intern Med 19(5):314–318
Su BY, Su CY, Yu SF, Chen CJ (2007) Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med Microbiol Immunol 196(3):165–170
Pope JE, Krizova A, Ouimet JM, Goodwin JL, Lankin M (2004) Close association of herpes zoster reactivation and systemic lupus erythematosus (SLE) diagnosis: case-control study of patients with SLE or noninflammatory nusculoskeletal disorders. J Rheumatol 31(2):274–279
Kawashiri S, Nakamura H, Kawakami A, Ida H, Izumi Y, Tamai M et al (2006) Emergence of Epstein-Barr virus-associated haemophagocytic syndrome upon treatment of systemic lupus erythematosus. Lupus 15(1):51–53
Khamaganova IV (1992) Herpetic infection in patients with lupus erythematosus. Ter Arkh 64(11):121–123
Nyberg G, Eriksson O, Westberg NG (1981) Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy. Arthritis Rheum 24(5):648–650
Bateman H, Yazici Y, Leff L, Peterson M, Paget SA (2000) Increased cervical dysplasia in intravenous cyclophosphamide-treated patients with SLE: a preliminary study. Lupus 9(7):542–544
Kay S, Frable WJ, Hume DM (1970) Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation. Cancer 26(5):1048–1052
Acknowledgments
M.S. receives a scholarship from the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Conflict of interest
The authors have no conflict of interest that is directly relevant to the content of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lyrio, L.D.C., Grassi, M.F.R., Santana, I.U. et al. Prevalence of cervical human papillomavirus infection in women with systemic lupus erythematosus. Rheumatol Int 33, 335–340 (2013). https://doi.org/10.1007/s00296-012-2426-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2426-0